No AGE/ Statin
(
n
=
36
)
AGE / No Statin
(
n
=
46
)
AGE / Statin
(
n
=
31
)
P
-value
CACs Progression Ratio
12.8 (-0.7, 27.9)
11.1 (0.0, 34.7)
15.6 (5.6, 31.6)
0.94
Statin therapy does not have an appreciable influence on CAC progression. Data presented as Median (Quartile 1, Quartile 3),
p
-value from median test.
Table 2:
Pooled CAC Progression by AGE and Statin Treatment Groups.
